Jiangsu Hengrui Medicine Co., Ltd.
Clinical trials sponsored by Jiangsu Hengrui Medicine Co., Ltd., explained in plain language.
-
Promising combo tackles tough liver cancer
Disease control CompletedThis study tested a combination of two drugs—SHR-1210 (an immunotherapy) and apatinib (a targeted therapy)—in 190 adults with advanced liver cancer that had not responded to or could not tolerate prior treatment. The goal was to see if the combo could shrink tumors and control th…
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:24 UTC
-
New muscle relaxant aims to make breathing tube insertion safer during surgery
Disease control CompletedThis study tested a new drug called HRS-9190 in 70 adults having planned surgery. The drug is a muscle relaxant given to help doctors place a breathing tube more easily during general anesthesia. The study compared HRS-9190 to a standard muscle relaxant to see if it works as well…
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:22 UTC
-
New drug shows promise for Hard-to-Treat stomach and colon cancers
Disease control CompletedThis early-phase study tested an experimental drug called SHR-A1811 in 101 people with advanced stomach or colorectal cancers that have a specific marker (HER2). The goal was to find a safe dose and see if the drug can shrink tumors. Participants had cancers that stopped respondi…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
IVF pill could replace daily shots in new study
Disease control CompletedThis study tested whether an oral medication (SHR7280) works as well as a standard injectable drug (ganirelix) for preventing early ovulation in women undergoing IVF. About 317 women participated. The goal was to see if the pill could offer a more convenient option without reduci…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
New drug targets hard-to-treat cancers in early trial
Disease control CompletedThis early-phase study tested an experimental drug called SHR-A1811 in 396 adults with advanced solid tumors that have a specific marker (HER2). The main goal was to check safety and how the drug moves through the body. Researchers also looked for signs that the drug might shrink…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:06 UTC
-
New gout pill shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new tablet called HR091506 in 765 adults with gout and high uric acid. The goal was to see if it could safely lower uric acid levels compared to an existing drug, febuxostat. Participants took the medicine for 28 weeks, and doctors checked their uric acid leve…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New sedative shows promise for Long-Term ICU sedation
Symptom relief CompletedThis study tested a drug called remimazolam tosilate to keep ICU patients calm and comfortable while on a breathing machine for three days or more. Twenty-four adults took part to see if the drug works well and is safe. The goal was to find a better way to manage sedation in crit…
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
New drug interaction study completed in healthy men
Knowledge-focused CompletedThis study looked at how a new drug called SHR7280 affects the way the body processes other common medicines. Twenty healthy men took SHR7280 along with several other drugs to see if there were any changes in drug levels or side effects. The goal was to gather important safety in…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 05:25 UTC
-
New muscle relaxant passes first safety check in healthy people
Knowledge-focused CompletedThis early-stage study tested a new drug called HRS-9190 in 49 healthy adults to see if it is safe and how the body processes it. The drug is designed to relax muscles, and researchers measured side effects, drug levels, and heart effects. The study also looked at how well a comm…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 05:24 UTC
-
New Injection's drug interaction checked in healthy volunteers
Knowledge-focused CompletedThis study looked at how a new injection called HRS-8427 changes the way the body processes two other drugs (bupropion and midazolam) in 14 healthy adults. The goal was to see if HRS-8427 affects liver enzymes that break down many medications. Results will help doctors understand…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 05:07 UTC
-
New painkiller formula tested in healthy volunteers
Knowledge-focused CompletedThis study checked if a new version of a long-lasting painkiller (bupivacaine liposome injection) works the same as the approved one. 36 healthy adults aged 18-45 took part. Researchers measured how the drug moves through the body and looked for side effects. The goal was to see …
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 05:07 UTC
-
Large Real-World study tracks safety of anesthesia drug remimazolam
Knowledge-focused CompletedThis study looked at the safety of a drug called remimazolam (Rebenin) when used for general anesthesia and sedation during a bronchoscopy (a procedure to look inside the lungs). Researchers observed over 1,200 patients in China to record any side effects. The goal was to gather …
Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 05:06 UTC